What is the recommended treatment for a 33-year-old female with iron deficiency anemia (hemoglobin 8.9 g/dL, hematocrit 30.8 %, mean corpuscular volume 69.5 fL, mean corpuscular hemoglobin 20.1 pg, mean corpuscular hemoglobin concentration 28.9 g/dL, red cell distribution width 16.5 %, ferritin 3 ng/mL, serum iron 11 µg/dL, total iron‑binding capacity 443 µg/dL, transferrin saturation 2 %)?

Treatment Recommendation for Severe Iron Deficiency Anemia

Start oral iron supplementation immediately with 50-100 mg elemental iron once daily (e.g., ferrous sulfate 200 mg tablet) taken on an empty stomach, and consider intravenous iron if she is symptomatic or fails to respond within 2 weeks. 1

Severity Assessment

This patient has severe iron deficiency anemia with:

• Hemoglobin 8.9 g/dL (moderate anemia)
• Ferritin 3 ng/mL (profound iron store depletion)
• Transferrin saturation 2% (severe functional iron deficiency)
• Microcytic indices (MCV 69.5 fL, MCH 20.1 pg, MCHC 28.9 g/dL)

The extremely low ferritin and transferrin saturation indicate complete depletion of iron stores requiring aggressive repletion.

Initial Treatment Strategy

First-Line: Oral Iron Therapy

Dosing regimen: 50-100 mg elemental iron once daily in the fasting state is the optimal compromise between efficacy and tolerability 1. This translates to:

• Ferrous sulfate 200 mg tablet (65 mg elemental iron) once daily, OR
• Ferrous fumarate 210 mg tablet (69 mg elemental iron) once daily

Key points:

• Take on an empty stomach for maximum absorption
• Once-daily dosing is as effective as multiple daily doses with better tolerability 1
• Alternate-day dosing (if GI side effects occur) produces similar hemoglobin increments with significantly lower nausea rates 1

When to Switch to Intravenous Iron

Consider IV iron as first-line or early switch if:

• Symptomatic anemia (severe fatigue, dyspnea, circulatory compromise) 1
• No hemoglobin rise of at least 10 g/L after 2 weeks of oral therapy (90% sensitivity for predicting treatment failure) 1
• GI intolerance to oral iron (nausea, constipation, abdominal pain)
• Suspected malabsorption (celiac disease, inflammatory bowel disease, H. pylori gastritis)
• Ongoing blood loss that cannot be controlled

IV iron produces clinically meaningful hemoglobin response within one week and should always be considered as an alternative to transfusion 1.

Monitoring Protocol

Early Response Assessment (Critical)

• Recheck hemoglobin at 2 weeks: Absence of ≥10 g/L rise strongly predicts treatment failure 1
• If inadequate response at 2 weeks → switch to IV iron or investigate causes of failure

Ongoing Monitoring

• Hemoglobin every 4 weeks until normalized 1
• Continue oral iron for 2-3 months after hemoglobin normalization to replenish iron stores 1
• Target hemoglobin: normal range for age/sex (>12 g/dL for women)
• Target ferritin: >30-50 ng/mL minimum, ideally >100 ng/mL for complete repletion

Blood Transfusion Consideration

Transfusion is NOT indicated in this case unless she develops:

• Severe symptomatic anemia with circulatory compromise
• Hemodynamic instability
• Unstable coronary artery disease

Blood transfusion is rarely required for slowly developing IDA because patients adapt physiologically, and IV iron produces rapid response within a week 1. If transfusion were needed, target hemoglobin would be 70-90 g/L (80-100 g/L with cardiac disease), followed by iron replacement since transfusion alone does not replenish iron stores 1.

Underlying Cause Investigation

This 33-year-old woman requires evaluation for the source of iron deficiency:

Most Likely Causes in Reproductive-Age Women:

1. Heavy menstrual bleeding (most common) - document menstrual history 2, 3
2. Gastrointestinal blood loss - even without overt bleeding
3. Malabsorption - celiac disease, H. pylori gastritis, atrophic gastritis

Recommended Workup:

• Gynecologic evaluation for menorrhagia/heavy menstrual bleeding
• Celiac disease screening with tissue transglutaminase antibody (IgA) and total IgA 4
• H. pylori testing 2
• Bidirectional endoscopy (gastroscopy and colonoscopy) if:
  • No clear gynecologic cause identified
  • Persistent anemia despite treatment
  • Any GI symptoms or red flags
  • Age >40 years (lower threshold for GI investigation) 4

Common Pitfalls to Avoid

1. Don't wait too long to switch to IV iron - 2 weeks is the decision point 1
2. Don't use modified-release oral iron preparations - they are less suitable for prescribing 1
3. Don't stop iron too early - continue 2-3 months after hemoglobin normalizes to replenish stores 1
4. Don't assume menstrual bleeding is the only cause - investigate for GI pathology if response is inadequate
5. Don't prescribe multiple daily doses initially - once-daily dosing improves compliance with similar efficacy 1

Treatment Failure Causes

If inadequate response occurs, consider:

• Non-compliance (most common)
• Ongoing blood loss (menstrual or GI)
• Malabsorption (celiac, IBD, H. pylori, post-bariatric surgery)
• Chronic inflammation (increases hepcidin, blocks iron absorption)
• Concurrent B12 or folate deficiency
• Bone marrow pathology
• Hemolysis 1